DOCSLIB.ORG

A Cancer Journal for Clinicians - Author Guidelines - Wiley Online Library 08/06/16 12:57

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Cancer Journal for Clinicians - Author Guidelines - Wiley Online Library 08/06/16 12:57 CA: A Cancer Journal for Clinicians - Author Guidelines - Wiley Online Library 08/06/16 12:57 You have free access to this content CA: A Cancer Journal for Clinicians © American Cancer Society Edited By: Otis Webb Brawley, MD, and Ted Gansler, MD, MBA, MPH Impact Factor: 144.8 ISI Journal Citation Reports © Ranking: 2014: 1/211 (Oncology) Online ISSN: 1542-4863 Associated Title(s): Cancer (/doi/10.1002/(ISSN)1097-0142/home), Cancer Cytopathology (/doi/10.1002/(ISSN)1934-6638/home) Author Guidelines For additional tools visit Author Resources (http://olabout.wiley.com/WileyCDA/Section/id-404516.html) - an enhanced suite of online tools for Wiley Online Library journal authors, featuring Article Tracking, E-mail Publication Alerts, and Customized Research Tools. To download a PDF copy of these Author Guidelines, please click here (CA_Author_Guidelines.pdf). Conflicts of Interest Disclosure Statement (http://www.icmje.org/coi_disclosure.pdf) Permission Request Form (http://www.wiley.com/legacy/authors/guidelines/stmguides/3-reqst.htm) Author Contribution Forms (http://onlinelibrary.wiley.com/store/10.1002/(ISSN)1097- 0142/asset/homepages/Contributorship_Form_checklist_credit_form.pdf? v=1&s=036ead8a34a45e5e9a35fe7aad96a90e040f870a&isAguDoi=false) All CORRESPONDENCE for the journal should be sent to the following address. Please include the manuscript ID with all correspondence (example: CA-16-0000) when applicable: CA: A Cancer Journal for Clinicians American Cancer Society 250 Williams Street NW Atlanta, GA 30303-1002 USA Phone: (404) 327-6411 Fax: (404) 417-8016 E-mail: [email protected] (mailto:[email protected]) Aims and Scope American Cancer Society Mission Submission Guidelines Authorship Review Process Production Journal-Based Continuing Education References AIMS AND SCOPE CA: A Cancer Journal for Clinicians is a peer-reviewed journal published for the American Cancer Society by John Wiley & Sons, Inc. CA publishes comprehensive review articles of a multidisciplinary nature, which take into account the journal’s diverse readership of primary care physicians; medical, surgical, and radiation oncologists; nurses; and other health care and public health professionals. Articles published in CA provide up-to-date information on all aspects of cancer prevention, early detection, treatment of all forms, palliation, advocacy, quality of life, and more. Unsolicited manuscripts must meet pre-submission requirements. AMERICAN CANCER SOCIETY MISSION The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives, and diminishing suffering from cancer through research, education, advocacy, and service. http://onlinelibrary.wiley.com/journal/10.3322/(ISSN)1542-4863/homepage/ForAuthors.html Page 1 of 7 CA: A Cancer Journal for Clinicians - Author Guidelines - Wiley Online Library 08/06/16 12:57 SUBMISSION GUIDELINES Note: Most CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for publication are generally not accepted for peer review. Case Reports and Letters to the Editor will not be considered for peer review or publication. • Manuscripts must be submitted to CA via ScholarOne Manuscripts (http://mc.manuscriptcentral.com/ca). Please contact the CA Editorial Office at (404) 327-6411 or [email protected] (mailto:[email protected]) if you have any questions about submitting your manuscript online. • All manuscripts must be submitted electronically using CA’s ScholarOne Manuscripts Web site available at mc.manuscriptcentral.com/ca (http://mc.manuscriptcentral.com/ca). Manuscripts may not be submitted by e-mail. • Submit text files only as .DOC, .DOCX, or .RTF file formats. Other file formats are not permitted and should be converted to .DOC or .DOCX. • Authors are required to e-mail or upoload any permissions that may have been obtained for figures or tables or any permissions required for patient consent. Please include the permanent manuscript ID on all correspondence (example: CA-16-0000). Pre-submission Requirements: Unsolicited Manuscripts CA requires pre-submission correspondence (consisting of an outline and abstract describing the proposed article) for review by the Editors before any unsolicited manuscript can be submitted for peer review. All unsolicited manuscripts submitted without the Editor's approval of a pre-submission outline and abstract will be returned without review. Please e-mail an abstract, full author list, manuscript length, and information about the author to the Editorial Office for consideration (see Editorial Office contact information below). Simultaneous Submission and Online Posting CA will not consider papers that are simultaneously submitted elsewhere or have been published (to include online). If a manuscript is posted to an author’s Web site (or their institution’s site), it must be taken down prior to submission. Manuscripts cannot be posted online until after the paper has been published in CA and only if permission has been granted by the publisher and the article properly cited. Manuscript Types • Review Articles: These articles should be literature reviews of cancer types, therapeutic modalities or strategies (including palliative care), or important issues in cancer prevention or early detection. Manuscripts of this type should be 25 to 40 double-spaced pages in length including references. Articles on very rare cancer types and highly specialized information on individual drugs or procedures are generally not appropriate for CA. • Editorials/Guest Editorials: Editorials are usually solicited; however, unsolicited editorials may be considered in some cases. Topics usually relate to the content of an article featured in the issue. Editorials are four to six double-spaced pages in length. • Commentaries: Commentaries are usually solicited. They present a point of view of general interest to the CA audience. • Department Articles: These articles cover current topics of interest to CA’s readership. Manuscripts should be 15 to 30 double-spaced pages in length. The length of solicited department articles will be addressed by the Editorial Office before submission. Departments include: • Complementary & Alternative Methods (CAM) refers to products and regimens that individuals may employ either to enhance wellness, relieve symptoms of disease and side effects of conventional treatments, or cure disease. CAM articles provide evidence-based information on promising complementary and alternative methods, and inform clinicians of methods that may harm patients. • Environmental Carcinogens articles deal with actual, potential, or perceived environmental and workplace carcinogens. Authors should highlight ways to advise patients about environmental exposures known or perceived to cause cancer by providing clear, concise information and advice that is based on laboratory and epidemiological research. • Emerging Trends in Basic Science articles cover issues related to basic research (including molecular and cellular biology, epidemiology, immunology, radiation physics and biology, information technology, and related fields). They should be geared toward clinicians with limited time who want to remain up to date on advances in basic science research and the current and future clinical implications of that research. • Perspectives: Research in Context is a section designed specifically for busy clinicians. It features practical, concise information that is accompanied by insight from noted experts in the fields of cancer prevention, detection, and treatment. This section is written in-house and external submissions are not accepted. • Patient Pages are written to provide general information on specific topics for patients and caregivers. Patient Pages are usually related to the content of the particular issue in which they appear. Patient Pages may be photocopied and given directly to patients. This section is written in-house and external submissions are not accepted. Supplements CA requires submission of an outline, which includes details on length, subject, authors (if available), and sponsorship information. Any supplement information that is received without the aforementioned items will be returned. This information must be provided for consideration by the Editors to determine appropriateness for CA's audience. All editorial materials, including supplements, are subject to peer review, and there is no guarantee of publication. All supplement costs must be borne by the authors or sponsoring group. Financial disclosures related to support should be provided in the cover letter. Copies of any related in-press publications should accompany manuscripts submitted to CA. Manuscript Format Manuscripts should follow the AMA Manual of Style (10th ed.)2 for grammar, punctuation, and style, and should meet the Uniform Requirements for Manuscripts Submitted to Biomedical Journals1 established by the ICMJE for general authorship guidelines. Title Page The following items are required on the title page: • Manuscript title. • Running title: a short version of the title (up to 40 characters including spaces). • Each author's name, academic degrees, and affiliation (all affiliations must be translated into standard English). Group members who do not meet the formal authorship criteria listed below but who contributed materially may be recognized in the Acknowledgments section. • Complete mailing address,
Load more

Recommended publications
  • PCHHAX Overview of Flaxseed Patent
    Available online a t www.derpharmachemica.com ISSN 0975-413X Der Pharma Chemica, 2016, 8(14):33-38 CODEN (USA): PCHHAX (http://derpharmachemica.com/archive.html) Overview of Flaxseed Patent Applications for the prevention and treatment of human cancer Sepideh Miraj Infertility Fellowship, Medicinal Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran _____________________________________________________________________________________________ ABSTRACT Flaxseed, Linum usitatissimum, is a member of the genus Linum in the family Linaceae. It is a food and fiber crop cultivated in cooler regions of the world. The aim of this study is to overview its anti-cancer and anti-tumor effects. This review article was carried out by searching studies in PubMed, Medline, Web of Science, and IranMedex databases up to 2016.totally, of 1 08 found articles, 41 articles were included. The search terms were “Flaxseed. ”, “therapeutic”, “pharmacological”, anticancer, anti-tumor. Various studies have shown that Flaxseed. Possess Anti-Breast Cancer properties, Anti-Breast tumors properties , Anti-Ovary cancer properties, Gut-associated diseases properties, Lung tumor properties, Inflammation properties, Anti-Skin Carcinogenesis properties, Pro- carcinogenic, Mastalgia properties, Aortic remodeling ,Anti-mammary Cancer effect ,Antioxidant and Antiproliferative ,Colon cancer properties, Esophagitis properties, Apoptosis properties. Flaxseed possess lots of therapeutic and pharmacological effects.in this study, its anticancer, anti-tumor effects was overviewed. Keywords : Flaxseed, therapeutic, pharmacological, anticancer, anti-tumor. _____________________________________________________________________________________________ INTRODUCTION It is proved that herbal medicine is effective in the treatment of many diseases [1-10].Flax, Linum usitatissimum , is a member of the genus Linum in the family Linaceae. It is a food and fiber crop cultivated in cooler regions of the world.
    [Show full text]
  • A Bibliometric Analysis
    787 Original Article Page 1 of 9 The 100 most cited articles on lung cancer screening: a bibliometric analysis Meng Li1,2, Qiang Cai2,3, Jing-Wen Ma1, Li Zhang1,2, Claudia I. Henschke2 1Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of Radiology, Mount Sinai Health System, New York, NY, USA; 3Department of Radiology, Shanxi Provincial People’s Hospital, Taiyuan, China Contributions: (I) Conception and design: M Li, CI Henschke; (II) Administrative support: CI Henschke; (III) Provision of study materials or patients: M Li, CI Henschke; (IV) Collection and assembly of data: M Li, L Zhang; (V) Data analysis and interpretation: M Li, Q Cai, JW Ma; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Claudia I. Henschke. Department of Radiology, Mount Sinai Health System, 1 Gustave Levy Place, New York, NY 10029, USA. Email: [email protected]. Background: The number of citations of an article reflects its impact on the scientific community. The aim of this study was to identify and characterize the 100 most cited articles on lung cancer screening. Methods: The 100 most cited articles on lung cancer screening published in all scientific journals were identified using the Web of Science database. Relevant data, including the number of citations, publication year, publishing journal and impact factor (IF), authorship and country of origin, article type and study design, screening modality, and main topic, were collected and analyzed. Results: The 100 most cited articles were all English and published between 1973 and 2017, with 81 published after 2000.
    [Show full text]
  • Cancer Treatment and Survivorship Facts & Figures 2019-2021
    Cancer Treatment & Survivorship Facts & Figures 2019-2021 Estimated Numbers of Cancer Survivors by State as of January 1, 2019 WA 386,540 NH MT VT 84,080 ME ND 95,540 59,970 38,430 34,360 OR MN 213,620 300,980 MA ID 434,230 77,860 SD WI NY 42,810 313,370 1,105,550 WY MI 33,310 RI 570,760 67,900 IA PA NE CT 243,410 NV 185,720 771,120 108,500 OH 132,950 NJ 543,190 UT IL IN 581,350 115,840 651,810 296,940 DE 55,460 CA CO WV 225,470 1,888,480 KS 117,070 VA MO MD 275,420 151,950 408,060 300,200 KY 254,780 DC 18,750 NC TN 470,120 AZ OK 326,530 NM 207,260 AR 392,530 111,620 SC 143,320 280,890 GA AL MS 446,900 135,260 244,320 TX 1,140,170 LA 232,100 AK 36,550 FL 1,482,090 US 16,920,370 HI 84,960 States estimates do not sum to US total due to rounding. Source: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute. Contents Introduction 1 Long-term Survivorship 24 Who Are Cancer Survivors? 1 Quality of Life 24 How Many People Have a History of Cancer? 2 Financial Hardship among Cancer Survivors 26 Cancer Treatment and Common Side Effects 4 Regaining and Improving Health through Healthy Behaviors 26 Cancer Survival and Access to Care 5 Concerns of Caregivers and Families 28 Selected Cancers 6 The Future of Cancer Survivorship in Breast (Female) 6 the United States 28 Cancers in Children and Adolescents 9 The American Cancer Society 30 Colon and Rectum 10 How the American Cancer Society Saves Lives 30 Leukemia and Lymphoma 12 Research 34 Lung and Bronchus 15 Advocacy 34 Melanoma of the Skin 16 Prostate 16 Sources of Statistics 36 Testis 17 References 37 Thyroid 19 Acknowledgments 45 Urinary Bladder 19 Uterine Corpus 21 Navigating the Cancer Experience: Treatment and Supportive Care 22 Making Decisions about Cancer Care 22 Cancer Rehabilitation 22 Psychosocial Care 23 Palliative Care 23 Transitioning to Long-term Survivorship 23 This publication attempts to summarize current scientific information about Global Headquarters: American Cancer Society Inc.
    [Show full text]
  • PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Factor/Rating. any Information publication published Reviewed Name of the Name of the IF exclusion (Yes/No) (Yes/No) indexing data assigning agency. criteria for base Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 1 Acta cytologica Karger, Basel 1957 Yes Yes 0001-5547(Print); Yes Indexed (Index 1.562 (Impact (Switzerland) 1938- medicus, Medline, Factor by Thomson 2650(Electronic); Pubmed) Reuters) 0001-5547(Linking) 2 Acta oncologica Informa Healthcare, 1987 No Yes 0284-186X(Print); Yes Indexed (Index 3.730 (Impact London (England) 1651- medicus, Medline, Factor by Thomson 226X(Electronic); Pubmed) Reuters) 0284-186X(Linking) 3 Advances in anatomic pathology Lippincott Williams 1994 Yes Yes 1072-4109(Print); Yes Indexed (Index 2.919 (Impact & Wilkins, 1533- medicus, Medline, Factor by Thomson Hagerstown, MD 4031(Electronic); Pubmed) Reuters) 1072-4109(Linking) 4 American journal of clinical oncology Lippincott Williams 1982 Yes Yes 0277-3732(Print); Yes Indexed (Index 2.977 (Impact & Wilkins, 1537- medicus, Medline, Factor by Thomson Hagerstown, MD 453X(Electronic); Pubmed) Reuters) 0277-3732(Linking) Sl.
    [Show full text]
  • Integrative Oncology from a Bibliometric Point of View T Jenny-Ann Brodin Danell
    Complementary Therapies in Medicine 52 (2020) 102477 Contents lists available at ScienceDirect Complementary Therapies in Medicine journal homepage: www.elsevier.com/locate/ctim Integrative oncology from a bibliometric point of view T Jenny-Ann Brodin Danell Department of Sociology, Umeå University, 901 87 Umeå, Sweden ARTICLE INFO ABSTRACT keywords: Objectives: The aim of this article is to analyze the development of integrative oncology from a bibliometric point Integrative oncology of view. The publication and citation patterns of publications are analyzed and their contents mapped. Complementary therapies Design: This study is based on bibliometric methods. The data sets consist of 7 025 respectively 4 990 pub- Research domain lications over the time period 1966-2016, shown in PubMed and Web of Science. Bibliometric methods Results: The expansion of the numbers of these publications took place in the late 1990s/early 2000s. Research is Citation analysis dominated by authors located in the USA, China and Germany who are working at well-established research Content analysis universities and university hospitals. The clinical share of publications is relatively small, and few studies are classified according to clinical phase. Content analysis revealed that much of the clinical research is based on surveys, and that content reflects the intersection of complementary therapies and cancer research. The latter aspect is less obvious in pre-clinical research. The most frequent journals in the material show a focus on complementary and alternative therapies or on integrative oncology, although journals focused on oncology or general/internal medicine were well-represented in the material as a whole. The most-cited publications were review articles and surveys.
    [Show full text]
  • An American Cancer Society Guide for Informed Choices Downloaded from Colleen Doyle, MS, RD; Lawrence H
    Downloaded from Nutrition and Physical Activity During and After Cancer Treatment: An American caonline.amcancersoc.org Cancer Society Guide for Informed Choices Colleen Doyle, Lawrence H. Kushi, Tim Byers, Kerry S. Courneya, Wendy Demark-Wahnefried, Barbara Grant, Anne McTiernan, Cheryl L. Rock, Cyndi Thompson, Ted Gansler, Kimberly S. Andrews and for the 2006 Nutrition, Physical Activity and Cancer Survivorship Advisory Committee CA Cancer J Clin 2006;56;323-353 DOI: 10.3322/canjclin.56.6.323 by on August 5, 2009 (©American Cancer Society, Inc.) This information is current as of August 5, 2009 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://caonline.amcancersoc.org/cgi/content/full/56/6/323 To subscribe to the print issue of CA: A Cancer Journal for Clinicians, go to (US individuals only): http://caonline.amcancersoc.org/subscriptions/ CA: A Cancer Journal for Clinicians is published six times per year for the American Cancer Society by Wiley-Blackwell. A bimonthly publication, it has been published continuously since November 1950. CA is owned, published, and trademarked by the American Cancer Society, 250 Williams Street NW, Atlanta GA 30303. (©American Cancer Society, Inc.) All rights reserved. Print ISSN: 0007-9235. Online ISSN: 1542-4863. CA Cancer J Clin 2006;56:323–353 Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices Downloaded from Colleen Doyle, MS, RD; Lawrence H. Kushi, ScD; Tim Byers, MD, MPH; Ms. Doyle is Director, Nutrition and Kerry S. Courneya, PhD; Wendy Demark-Wahnefried, PhD, RD, LDN; Barbara Grant, MS, Physical Activity, American Cancer Society, Atlanta, GA.
    [Show full text]
  • Unconventional Cancer Treatments
    Unconventional Cancer Treatments September 1990 OTA-H-405 NTIS order #PB91-104893 Recommended Citation: U.S. Congress, Office of Technology Assessment, Unconventional Cancer Treatments, OTA-H-405 (Washington, DC: U.S. Government Printing Office, September 1990). For sale by the Superintendent of Documents U.S. Government Printing OffIce, Washington, DC 20402-9325 (order form can be found in the back of this report) Foreword A diagnosis of cancer can transform abruptly the lives of patients and those around them, as individuals attempt to cope with the changed circumstances of their lives and the strong emotions evoked by the disease. While mainstream medicine can improve the prospects for long-term survival for about half of the approximately one million Americans diagnosed with cancer each year, the rest will die of their disease within a few years. There remains a degree of uncertainty and desperation associated with “facing the odds” in cancer treatment. To thousands of patients, mainstream medicine’s role in cancer treatment is not sufficient. Instead, they seek to supplement or supplant conventional cancer treatments with a variety of treatments that exist outside, at varying distances from, the bounds of mainstream medical research and practice. The range is broad—from supportive psychological approaches used as adjuncts to standard treatments, to a variety of practices that reject the norms of mainstream medical practice. To many patients, the attractiveness of such unconventional cancer treatments may stem in part from the acknowledged inadequacies of current medically-accepted treatments, and from the too frequent inattention of mainstream medical research and practice to the wider dimensions of a cancer patient’s concerns.
    [Show full text]
  • Web of Science™ Core Collection Current Contents Connect®
    WEB OF SCIENCE™ CORE COLLECTION CURRENT CONTENTS CONNECT® XML USER GUIDE March, 2020 Table of Contents Overview 3 Support and Questions 4 Selection Criteria 5 XML Schemas 7 Schema Diagram 8 Source Record Identifiers 9 Document and Source Titles 11 Source Author Names 12 Full Names and Abbreviations 13 Chinese Author Names 13 Authors and Addresses 15 Research and Reprint Addresses 17 Organizations 18 Contributors 19 Cited References 21 Citations to Articles from Journal Supplements 22 Issue Information in the Volume Field 23 Cited Authors in References to Proceedings and Patents 23 © 2020 Clarivate Analytics 1 Counting Citations 24 Times Cited File 25 Delivery Schedule 26 Corrections and Gap Records 27 Deletions 28 Journal Lists and Journal Changes 29 Appendix 1 Subject Categories 30 Subject Catagories (Ascatype) 30 Web of Science™ Core Collection Subject Areas (Traditional Ascatype) 30 Research Areas (Extended Ascatype) 34 Current Contents Subject Codes 38 Current Contents Editions and Subjects 38 Appendix 2 Document Types 43 Document Types 43 Web of Science Core Collection Document Types 43 Current Contents Connect Document Types 44 Appendix 3 Abbreviations and Acronyms 46 Address Abbreviations 46 Country Abbreviations 51 Cited Patent Country Abbreviations 57 © 2020 Clarivate Analytics 2 Overview Your contract for raw data entitles you to get timely updates, which you may store and process according to the terms of your agreement. The associated XML schemas describe the record structure of the data and the individual elements that define
    [Show full text]
  • SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total Journals: 8631
    SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total journals: 8631 1. 4OR-A QUARTERLY JOURNAL OF OPERATIONS RESEARCH 2. AAPG BULLETIN 3. AAPS JOURNAL 4. AAPS PHARMSCITECH 5. AATCC REVIEW 6. ABDOMINAL IMAGING 7. ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG 8. ABSTRACT AND APPLIED ANALYSIS 9. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 10. ACADEMIC EMERGENCY MEDICINE 11. ACADEMIC MEDICINE 12. ACADEMIC PEDIATRICS 13. ACADEMIC RADIOLOGY 14. ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE 15. ACCOUNTS OF CHEMICAL RESEARCH 16. ACCREDITATION AND QUALITY ASSURANCE 17. ACI MATERIALS JOURNAL 18. ACI STRUCTURAL JOURNAL 19. ACM COMPUTING SURVEYS 20. ACM JOURNAL ON EMERGING TECHNOLOGIES IN COMPUTING SYSTEMS 21. ACM SIGCOMM COMPUTER COMMUNICATION REVIEW 22. ACM SIGPLAN NOTICES 23. ACM TRANSACTIONS ON ALGORITHMS 24. ACM TRANSACTIONS ON APPLIED PERCEPTION 25. ACM TRANSACTIONS ON ARCHITECTURE AND CODE OPTIMIZATION 26. ACM TRANSACTIONS ON AUTONOMOUS AND ADAPTIVE SYSTEMS 27. ACM TRANSACTIONS ON COMPUTATIONAL LOGIC 28. ACM TRANSACTIONS ON COMPUTER SYSTEMS 29. ACM TRANSACTIONS ON COMPUTER-HUMAN INTERACTION 30. ACM TRANSACTIONS ON DATABASE SYSTEMS 31. ACM TRANSACTIONS ON DESIGN AUTOMATION OF ELECTRONIC SYSTEMS 32. ACM TRANSACTIONS ON EMBEDDED COMPUTING SYSTEMS 33. ACM TRANSACTIONS ON GRAPHICS 34. ACM TRANSACTIONS ON INFORMATION AND SYSTEM SECURITY 35. ACM TRANSACTIONS ON INFORMATION SYSTEMS 36. ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY 37. ACM TRANSACTIONS ON INTERNET TECHNOLOGY 38. ACM TRANSACTIONS ON KNOWLEDGE DISCOVERY FROM DATA 39. ACM TRANSACTIONS ON MATHEMATICAL SOFTWARE 40. ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION 41. ACM TRANSACTIONS ON MULTIMEDIA COMPUTING COMMUNICATIONS AND APPLICATIONS 42. ACM TRANSACTIONS ON PROGRAMMING LANGUAGES AND SYSTEMS 43. ACM TRANSACTIONS ON RECONFIGURABLE TECHNOLOGY AND SYSTEMS 44.
    [Show full text]
  • How to Cite Complete Issue More Information About This Article
    Vigilância Sanitária em Debate ISSN: 2317-269X INCQS-FIOCRUZ Souza, Diego de Oliveira A saúde dos trabalhadores e a pandemia de COVID-19: da revisão à crítica Vigilância Sanitária em Debate, vol. 8, no. 3, 2020, July-September, pp. 125-131 INCQS-FIOCRUZ DOI: https://doi.org/10.22239/2317-269X.01627 Available in: https://www.redalyc.org/articulo.oa?id=570566811014 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative REVIEW https://doi.org/10.22239/2317-269x.01627 The health of workers and COVID-19 pandemic: from review to criticism A saúde dos trabalhadores e a pandemia de COVID-19: da revisão à crítica ABSTRACT Diego de Oliveira Souza* Introduction: With the emergence of the COVID-19 pandemic, science needs to give quick answers. The context has been violent, especially for workers. Objective: critically summarize the main scientific recommendations for workers in the face of the COVID-19 pandemic. Method: This is a literature review from PubMed e VHL, in which 19 publications were obtained for analysis. Results: In the literature, emphasis was placed on the issue of PPE, hygiene measures and other individual measures. Some studies address organizational issues and surveillance for healthcare workers, but also for workers in general. Conclusions: In addition to the synthesis of publications, the review contributes with reflections and provocations with a view to further interventions. KEYWORDS: Coronavirus; Pandemics; Occupational Health; Work RESUMO Introdução: Em meio a um contexto atípico, com a emergência da pandemia de COVID-19, a ciência precisa dar respostas na mesma velocidade da propagação do SARS-CoV-2.
    [Show full text]
  • American Society for Colposcopy and Cervical Pathology
    American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer Debbie Saslow, PhD,1 Diane Solomon, MD,2 Herschel W. Lawson, MD,3 Maureen Killackey, MD,4 Shalini L. Kulasingam, PhD,5 Joanna Cain, MD, FACOG,6 Francisco A. R. Garcia, MD, MPH,7 Ann T. Moriarty, MD,8 Alan G. Waxman, MD, MPH,9 David C. Wilbur, MD,10 Nicolas Wentzensen, MD, PhD, MS,11 Levi S. Downs, Jr, MD,12 Mark Spitzer, MD,13 Anna-Barbara Moscicki, MD,14 Eduardo L. Franco, DrPH,15 Mark H. Stoler, MD,16 Mark Schiffman, MD,17 Philip E. Castle, PhD, MPH,18* and Evan R. Myers, MD, MPH19* 1Director, Breast and Gynecologic Cancer, Cancer Control Science Department, American Cancer Society, Atlanta, GA, on behalf of the Steering Committee, Data Group, and Writing Committee; 2Senior Investigator, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD, on behalf of the Steering Committee; 3Adjunct Associate Professor, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, on behalf of the Data Group; 4Deputy Physician in Chief, Medical Director, Memorial Sloan-Kettering Cancer Center Regional Network, Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, Correspondence to: Debbie Saslow, PhD, Director, Breast and Gyneco- Disclaimers: The contents of the paper are solely the responsibility of logic Cancer, American Cancer Society, 250 Williams St NW, Suite 600, the authors and do not necessarily represent the official views of the Atlanta, GA 30303.
    [Show full text]
  • Legislative Scorecard 2019
    American Cancer Society Cancer Action Network Legislative Scorecard 2019 fightcancer.org American Cancer Society Cancer Action Network Legislative Scorecard 2019 The American Cancer Society Cancer Action Network (ACS CAN) Other legislation ACS CAN supported in 2019 that was passed empowers cancer patients, survivors, their families and other and enacted included reducing cancer-causing pollution health advocates by amplifying their voices in the halls of from medium- and heavy-duty vehicles by reducing the level government. As such, ACS CAN is a powerful force in shaping of greenhouse gas emissions allowed, as well as improving policies that fight cancer. We mobilize our large grassroots emission standards. Another bill we championed will require network to elevate cancer as a priority with lawmakers at the manufacturers of cosmetic products to disclose potentially local, state and federal levels. cancer-causing ingredients on a public website. In California, ACS CAN and its volunteer advocates influence On the tobacco control front, ACS CAN and its volunteer evidence-based legislation and regulatory solutions that will advocates were tireless in spotlighting the influence of the reduce the cancer burden. As the American Cancer Society’s tobacco industry at the Capitol and in particular Juul Labs, nonprofit, nonpartisan advocacy affiliate, ACS CAN is critical to which the Federal Drug Administration (FDA) says is behind a the fight for a world without cancer. nationwide youth e-cigarette epidemic. While Congress and the courts considered changes to the health New data from the FDA in 2019 showed that the youth use care law in 2019 that would decrease enrollment in health of e-cigarettes in high school is skyrocketing, with a 135% exchanges fostered by the landmark Affordable Care Act, ACS CAN increase over the past two years.
    [Show full text]